Oncolytics Biotech Inc. (ONCY)
NASDAQ: ONCY
· Real-Time Price · USD
0.99
-0.02 (-1.98%)
At close: Aug 19, 2025, 12:55 PM
-1.98% (1D)
| Bid | 0.98 |
| Market Cap | 95.63M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -31.5M |
| EPS (ttm) | -0.27 |
| PE Ratio (ttm) | -3.67 |
| Forward PE | -2.13 |
| Analyst | Buy |
| Ask | 0.99 |
| Volume | 184,548 |
| Avg. Volume (20D) | 1,251,454 |
| Open | 1.01 |
| Previous Close | 1.01 |
| Day's Range | 0.98 - 1.04 |
| 52-Week Range | 0.33 - 1.53 |
| Beta | 1.48 |
About ONCY
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ONCY
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ONCY stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+34.1%
Oncolytics Biotech shares are trading higher after...
Unlock content with
Pro Subscription
4 months ago
+24.56%
Oncolytics Biotech shares are trading higher after the company secured up to $20 million in flexible funding for the development of Pelareorep through a share purchase agreement with Alumin Capital.
